Designing Therapeutic Peptides for Inhibiting the mTORC1 Signalling Pathway: A Novel Trend in Cancer Therapeutics
Cancer is the second leading cause of death globally, characterized by hallmark features including uncontrolled cell proliferation, enhanced survival, abnormal angiogenesis, immune evasion, and metabolic reprogramming. The mTOR signalling pathway intersects with all these hallmarks, positioning it a...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
EDP Sciences
2026-01-01
|
| Serija: | BIO Web of Conferences |
| Online pristup: | https://www.bio-conferences.org/articles/bioconf/pdf/2026/26/bioconf_icabb2026_01007.pdf |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|